Prot #INCB 52793-101: A Phase 1a/1b, Open-Label, Dose-Escalation, Safety and Tolerability Study of INCB052793 in Subjects With Advanced Malignancies

Project: Research project

Project Details

StatusFinished
Effective start/end date12/2/1512/2/18

Funding

  • Parexel (Prot #INCB 52793-101)
  • Incyte Corporation (Prot #INCB 52793-101)